Survival of elderly patients with multiple myeloma: effect of upfront autologous stem cell transplantation
Background: The aim of this study was to determine the value of upfront autologous transplantation (ASCT) in elderly patients (60-79 years) with myeloma. Methods: We analysed relative survival (RS) of patients diagnosed in 1998-2011 and treated with ASCT within 12 months after diagnosis in Germany (...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
July 2016
|
| In: |
European journal of cancer
Year: 2016, Jahrgang: 62, Pages: 1-8 |
| ISSN: | 1879-0852 |
| DOI: | 10.1016/j.ejca.2016.04.004 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1016/j.ejca.2016.04.004 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0959804916320627 
|
| Verfasserangaben: | Maximilian Merz, Lina Jansen, Felipe A. Castro, Jens Hillengass, Hans Salwender, Katja Weisel, Christof Scheid, Sabine Luttmann, Katharina Emrich, Bernd Holleczek, Alexander Katalinic, Alice Nennecke, Christian Straka, Christian Langer, Monika Engelhardt, Hermann Einsele, Nicolaus Kröger, Dietrich Beelen, Peter Dreger, Hermann Brenner, Hartmut Goldschmidt for the GEKID Cancer Survival Working Group and the DRST2 |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1540038866 | ||
| 003 | DE-627 | ||
| 005 | 20220812230703.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 160527s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejca.2016.04.004 |2 doi | |
| 035 | |a (DE-627)1540038866 | ||
| 035 | |a (DE-576)470038861 | ||
| 035 | |a (DE-599)BSZ470038861 | ||
| 035 | |a (OCoLC)1340919926 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Merz, Maximilian |d 1985- |e VerfasserIn |0 (DE-588)1023626950 |0 (DE-627)718419278 |0 (DE-576)367168251 |4 aut | |
| 245 | 1 | 0 | |a Survival of elderly patients with multiple myeloma |b effect of upfront autologous stem cell transplantation |c Maximilian Merz, Lina Jansen, Felipe A. Castro, Jens Hillengass, Hans Salwender, Katja Weisel, Christof Scheid, Sabine Luttmann, Katharina Emrich, Bernd Holleczek, Alexander Katalinic, Alice Nennecke, Christian Straka, Christian Langer, Monika Engelhardt, Hermann Einsele, Nicolaus Kröger, Dietrich Beelen, Peter Dreger, Hermann Brenner, Hartmut Goldschmidt for the GEKID Cancer Survival Working Group and the DRST2 |
| 264 | 1 | |c July 2016 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 27.05.2016 | ||
| 520 | |a Background: The aim of this study was to determine the value of upfront autologous transplantation (ASCT) in elderly patients (60-79 years) with myeloma. Methods: We analysed relative survival (RS) of patients diagnosed in 1998-2011 and treated with ASCT within 12 months after diagnosis in Germany (n = 3591; German Registry of Stem Cell Transplantation) and compare RS with survival of myeloma patients diagnosed in the same years in Germany (n = 13,903; population-based German Cancer Registries). Results: Utilisation of ASCT has increased rapidly between 2000-2002 and 2009-2011 (60-64years: 7.0-43.0%; 65-69 years: 6.6-23.7%; 70-79 years: 0.4-4.0%). Comparison of 5-year RS of patients from the general German myeloma population who have survived the first year after diagnosis with 5-year RS of patients treated with ASCT revealed higher survival for transplanted patients among all age groups (60-64: 59.2% versus 66.1%; 65-69: 57.4% versus 61.7%; 70-79: 51.0% versus 56.6%). RS increased strongly between 2003-2005 and 2009-2011 for the general German myeloma population (+8.5%) and for patients treated with ASCT (+11.8%). Differences in RS between these groups increased over time from +1.9% higher age-standardised survival in transplanted patients in 2003-2005 to 5.2% higher survival in 2009-2011. Conclusion: We conclude that upfront ASCT might be a major contributor to improved survival for elderly myeloma patients in Germany. | ||
| 650 | 4 | |a Autologous stem cell transplantation | |
| 650 | 4 | |a Elderly | |
| 650 | 4 | |a Multiple myeloma | |
| 650 | 4 | |a Population-based survival analysis | |
| 700 | 1 | |a Hillengaß, Jens |d 1974- |e VerfasserIn |0 (DE-588)124918549 |0 (DE-627)368073823 |0 (DE-576)294568298 |4 aut | |
| 700 | 1 | |a Dreger, Peter |e VerfasserIn |0 (DE-588)1028891881 |0 (DE-627)732699894 |0 (DE-576)376320966 |4 aut | |
| 700 | 1 | |a Brenner, Hermann |e VerfasserIn |0 (DE-588)1020516445 |0 (DE-627)691247005 |0 (DE-576)360642136 |4 aut | |
| 700 | 1 | |a Goldschmidt, Hartmut |d 1956- |e VerfasserIn |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of cancer |d Amsterdam [u.a.] : Elsevier, 1992 |g 62(2016), Seite 1-8 |w (DE-627)266883400 |w (DE-600)1468190-0 |w (DE-576)090954173 |x 1879-0852 |7 nnas |a Survival of elderly patients with multiple myeloma effect of upfront autologous stem cell transplantation |
| 773 | 1 | 8 | |g volume:62 |g year:2016 |g pages:1-8 |g extent:8 |a Survival of elderly patients with multiple myeloma effect of upfront autologous stem cell transplantation |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ejca.2016.04.004 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0959804916320627 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20160527 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |e 910000PG102258023X |e 910100PG102258023X |k 0/910000/ |k 1/910000/910100/ |p 21 |y j | ||
| 998 | |g 1020516445 |a Brenner, Hermann |m 1020516445:Brenner, Hermann |d 850000 |d 851600 |d 50000 |e 850000PB1020516445 |e 851600PB1020516445 |e 50000PB1020516445 |k 0/850000/ |k 1/850000/851600/ |k 0/50000/ |p 20 | ||
| 998 | |g 1028891881 |a Dreger, Peter |m 1028891881:Dreger, Peter |d 910000 |d 910100 |e 910000PD1028891881 |e 910100PD1028891881 |k 0/910000/ |k 1/910000/910100/ |p 19 | ||
| 998 | |g 124918549 |a Hillengaß, Jens |m 124918549:Hillengaß, Jens |d 910000 |d 910100 |e 910000PH124918549 |e 910100PH124918549 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 1023626950 |a Merz, Maximilian |m 1023626950:Merz, Maximilian |d 910000 |d 910100 |e 910000PM1023626950 |e 910100PM1023626950 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1540038866 |e 2926240651 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"family":"Merz","display":"Merz, Maximilian","role":"aut","given":"Maximilian"},{"given":"Jens","role":"aut","family":"Hillengaß","display":"Hillengaß, Jens"},{"family":"Dreger","display":"Dreger, Peter","role":"aut","given":"Peter"},{"role":"aut","display":"Brenner, Hermann","family":"Brenner","given":"Hermann"},{"given":"Hartmut","family":"Goldschmidt","display":"Goldschmidt, Hartmut","role":"aut"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"title":[{"title_sort":"European journal of cancer","title":"European journal of cancer"}],"language":["eng"],"id":{"issn":["1879-0852"],"zdb":["1468190-0"],"eki":["266883400"]},"origin":[{"dateIssuedKey":"1992","dateIssuedDisp":"1992-","publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","publisher":"Elsevier ; Pergamon Press"}],"corporate":[{"display":"European Organization for Research on Treatment of Cancer","role":"isb"},{"display":"European Association for Cancer Research","role":"isb"},{"display":"European School of Oncology","role":"isb"}],"pubHistory":["28.1992 -"],"disp":"Survival of elderly patients with multiple myeloma effect of upfront autologous stem cell transplantationEuropean journal of cancer","part":{"pages":"1-8","volume":"62","year":"2016","extent":"8","text":"62(2016), Seite 1-8"},"recId":"266883400","type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"EJC online"}]}],"origin":[{"dateIssuedDisp":"July 2016","dateIssuedKey":"2016"}],"id":{"doi":["10.1016/j.ejca.2016.04.004"],"eki":["1540038866"]},"recId":"1540038866","physDesc":[{"extent":"8 S."}],"language":["eng"],"title":[{"title":"Survival of elderly patients with multiple myeloma","subtitle":"effect of upfront autologous stem cell transplantation","title_sort":"Survival of elderly patients with multiple myeloma"}],"note":["Gesehen am 27.05.2016"],"name":{"displayForm":["Maximilian Merz, Lina Jansen, Felipe A. Castro, Jens Hillengass, Hans Salwender, Katja Weisel, Christof Scheid, Sabine Luttmann, Katharina Emrich, Bernd Holleczek, Alexander Katalinic, Alice Nennecke, Christian Straka, Christian Langer, Monika Engelhardt, Hermann Einsele, Nicolaus Kröger, Dietrich Beelen, Peter Dreger, Hermann Brenner, Hartmut Goldschmidt for the GEKID Cancer Survival Working Group and the DRST2"]}} | ||
| SRT | |a MERZMAXIMISURVIVALOF2016 | ||